Brief: Egetis Therapeutics Updates On Status Of ReTRIACt Trial

Egetis Therapeutics AB (publ)

19/12/2023 13:28

Dec 19 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * EGETIS THERAPEUTICS AB (PUBL) - UPDATES ON STATUS OF
RETRIACT
TRIAL
    * EGETIS THERAPEUTICS AB (PUBL) - HAS RECRUITED 7 PATIENTS,
OUT OF
TARGET OF 16 EVALUABLE PATIENTS
    * EGETIS - TO UPDATE MARKET ABOUT TIMING OF AVAILABILITY OF
TOP-LINE RESULTS, TIMING OF SUBSEQUENT NDA FILING AS SOON
RECRUITMENT HAS BEEN COMPLETED

Source text for Eikon:  ID:nMFN5d8WQ2 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))